A combination of p300 and Braf expression in the diagnosis and prognosis of melanoma
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A combination of p300 and Braf expression in the diagnosis and prognosis of melanoma
Authors
Keywords
p300, Braf, Melanoma, Prognosis, AJCC, Patient survival
Journal
BMC CANCER
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-06-04
DOI
10.1186/1471-2407-14-398
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phosphorylation of p300 increases its protein degradation to enhance the lung cancer progression
- (2014) Shao-An Wang et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Disease progression and patient survival are significantly influenced by BRAF protein expression in primary melanoma
- (2013) G. Safaee Ardekani et al. BRITISH JOURNAL OF DERMATOLOGY
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Decreased Expression of Nuclear p300 Is Associated with Disease Progression and Worse Prognosis of Melanoma Patients
- (2013) Anand Rotte et al. PLoS One
- Therapy for metastatic melanoma: the past, present, and future
- (2012) Laura Finn et al. BMC Medicine
- Targeting Mutant BRAF in Melanoma
- (2012) Ragini Kudchadkar et al. CANCER JOURNAL
- p300/CBP acetyl transferases interact with and acetylate the nucleotide excision repair factor XPG
- (2012) Micol Tillhon et al. DNA REPAIR
- Histone deacetylase inhibitors in the treatment of cancer: overview and perspectives
- (2012) Giuseppe Giannini et al. Future Medicinal Chemistry
- A phase I study of sorafenib and vorinostat in patients with advanced solid tumors with expanded cohorts in renal cell carcinoma and non-small cell lung cancer
- (2012) A. Dasari et al. INVESTIGATIONAL NEW DRUGS
- Role of Tip60 in Human Melanoma Cell Migration, Metastasis, and Patient Survival
- (2012) Guangdi Chen et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The dysplastic nevus: From historical perspective to management in the modern era
- (2012) Keith Duffy et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- p38 MAPK- and Akt-mediated p300 phosphorylation regulates its degradation to facilitate nucleotide excision repair
- (2012) Qi-En Wang et al. NUCLEIC ACIDS RESEARCH
- Phase II trial of the histone deacetylase inhibitor romidepsin in patients with recurrent/metastatic head and neck cancer
- (2012) Missak Haigentz et al. ORAL ONCOLOGY
- Novel Multiple Markers to Distinguish Melanoma from Dysplastic Nevi
- (2012) Guohong Zhang et al. PLoS One
- The Prognostic Value of BRAF Mutation in Colorectal Cancer and Melanoma: A Systematic Review and Meta-Analysis
- (2012) Gholamreza Safaee Ardekani et al. PLoS One
- Histone Deacetylase Inhibitors Induce Growth Arrest and Differentiation in Uveal Melanoma
- (2011) S. Landreville et al. CLINICAL CANCER RESEARCH
- Nucleotide excision repair in chromatin: Damage removal at the drop of a HAT
- (2011) Simon H. Reed DNA REPAIR
- Life and death of transcriptional co-activator p300
- (2011) Jihong Chen et al. Epigenetics
- Optimizing the Frequency of Follow-Up Visits for Patients Treated for Localized Primary Cutaneous Melanoma
- (2011) Robin M. Turner et al. JOURNAL OF CLINICAL ONCOLOGY
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cytoplasmic Skp2 Expression Is Increased in Human Melanoma and Correlated with Patient Survival
- (2011) Guangdi Chen et al. PLoS One
- Prognostic significance of RUNX3 expression in human melanoma
- (2010) Zhizhong Zhang et al. CANCER
- Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice
- (2010) Julien Bricambert et al. JOURNAL OF CLINICAL INVESTIGATION
- Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
- (2010) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Histone acetyl transferases as emerging drug targets
- (2009) Frank J. Dekker et al. DRUG DISCOVERY TODAY
- National Assessment of Melanoma Care Using Formally Developed Quality Indicators
- (2009) Karl Y. Bilimoria et al. JOURNAL OF CLINICAL ONCOLOGY
- Final Version of 2009 AJCC Melanoma Staging and Classification
- (2009) Charles M. Balch et al. JOURNAL OF CLINICAL ONCOLOGY
- A Decade of Tissue Microarrays: Progress in the Discovery and Validation of Cancer Biomarkers
- (2008) Robert L. Camp et al. JOURNAL OF CLINICAL ONCOLOGY
- The limited specificity of histological examination in the diagnosis of dysplastic nevi
- (2008) Michael S. Rabkin JOURNAL OF CUTANEOUS PATHOLOGY
- Transcriptional Modulation Using HDACi Depsipeptide Promotes Immune Cell-Mediated Tumor Destruction of Murine B16 Melanoma
- (2008) Takashi Murakami et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Spitz nevi: In vivo confocal microscopic features, dermatoscopic aspects, histopathologic correlates, and diagnostic significance
- (2008) Giovanni Pellacani et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started